Absolute lymphocyte counts predicts response to chemotherapy and survival in diffuse large B-cell lymphoma.

Kim, D H; Baek, J H; Chae, Y S; Kim, Y-K; Kim, H J; Park, Y H; Song, H S; Chung, J S; Hyun, M S; Sohn, S K

Kim, D H; Baek, J H; Chae, Y S; Kim, Y-K; Kim, H J; Park, Y H; Song, H S; Chung, J S; Hyun, M S; Sohn, S K.

Leukemia ; 21(10): 2227-30, 2007 Oct.

Article in En | MEDLINE | ID: mdl-17554383

Subject(s)

Lymphocytes/cytology; Lymphoma, B-Cell/drug therapy; Lymphoma, B-Cell/pathology; Lymphoma, Large B-Cell, Diffuse/drug therapy; Lymphoma, Large B-Cell, Diffuse/pathology; Antigens, CD20/biosynthesis; Antineoplastic Combined Chemotherapy Protocols/administration & dosage; Cyclophosphamide/administration & dosage; Doxorubicin/administration & dosage; Humans; Lymphocyte Count; Lymphoma, B-Cell/mortality; Lymphoma, Large B-Cell, Diffuse/mortality; Medical Oncology/methods; Multivariate Analysis; Odds Ratio; Prednisolone/administration & dosage; Prognosis; Time Factors; Treatment Outcome; Vincristine/administration & dosage

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Lymphocytes / Lymphoma, B-Cell / Lymphoma, Large B-Cell, Diffuse Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Leukemia Year: 2007 Document type: Article

Search on Google

XML

PubMed Links